Literature DB >> 4919582

In-vitro sensitivity of Shigella sonnei to trimethoprim and sulphamethoxazole.

K J Jarvis, G Scrimgeour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4919582     DOI： 10.1099/00222615-3-3-554

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  4 in total

1.  In vitro susceptibility of Shigella strains to trimethoprim and sulfamethoxazole.

Authors:  R C Rudoy; J D Nelson; K C Haltalin
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

2.  Susceptibility of shigellae to mecillinam, nalidixic acid, trimethoprim, and five other antimicrobial agents.

Authors:  H B Hansson; M Walder; I Juhlin
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

3.  Shigella species from Addis Ababa: frequency of isolation and in vitro drug sensitivity.

Authors:  M Gedebou; A Tassew
Journal:  J Hyg (Lond)       Date:  1982-02

Review 4.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.